Cart (0)
Your shopping cart is empty!
Detragel gel for external use 40g
Detragel gel for external use 40g
Product Code: detragel-40

Detragel gel for external use 40g

Compare this Product

Detragel (Detralex gel)


Active components in 1 g of the preparation:

    sodium heparin 100 IU
    essential phospholipids 10 mg
    escin 10 mg

Pharmacological action

Combined preparation, has local anticoagulant, anti-inflammatory, venotonizing and antiaggregant action, reduces vein permeability, improves microcirculation.

Detragel® contains three active substances: sodium heparin, essential phospholipids and escine, which have pharmacodynamic and pharmacokinetic synergism.

Sodium heparin is a direct-acting anticoagulant. Due to inactivation of biogenic amines and blocking of lysosomal enzymes in the tissue, shows anti-inflammatory action, accelerates the dissolution of microthrombi in the area of subcutaneous capillaries, prevents thrombosis, activates the fibrinolytic system, improves microcirculation, promotes regeneration of connective tissue by inhibiting the activity of hyaluronidase.

Essential phospholipids reduce blood viscosity due to the effect on fat metabolism, reduce platelet aggregation.

Eskin - venotonizing agent of plant origin. Prevents the activation of lysosomal enzymes that break down proteoglycan, increases the tone of the venous wall, eliminates venous stasis, reduces capillary permeability and fragility. Reduces exudation, reduces fluid effusion into tissues and accelerates the resorption of existing edema. Inhibits inflammation, improves microcirculation, promotes tissue repair.


    Therapy of symptoms of chronic vein diseases;
    varicose veins with symptoms in the form of pain, swelling, a feeling of heaviness and fatigue in the legs, night cramps of the calf muscles and with signs in the form of telangiectasias (vascular stars and meshes) and varicose veins;
    superficial phlebitis, thrombophlebitis;
    hematomas in trauma, including sports sprains and bruises;
    postoperative hematomas without violating the integrity of the skin.

Recommendations for use

For external use.

Gel is applied in a thin layer to the problem area of the skin and evenly distributed with light massaging movements, 2-3 times / day daily until the disappearance of symptoms.

If necessary, the gel can be applied under elastic stockings or bandages.

In thrombophlebitis should avoid rubbing the gel.

Contraindicated application of the gel on mucous membranes.

Duration of treatment - no more than 15 days. The possibility of a longer course of treatment is determined by a doctor.

If the condition worsened or improvement did not occur after 15 days, the patient should consult a doctor.

Do not exceed the recommended dose and duration of use of the drug.


    hypersensitivity to the drug components;
    hemorrhagic diathesis (including thrombocytopenic purpura);
    violation of skin integrity at the site of drug application (open wounds, ulcerative-necrotic lesions), burns, eczema, skin infections;
    contraindicated for use on mucous membranes;
    under 18 years of age (there is no experience of using the drug in children under 18 years of age).

Special indications

To date, there have been no reports of undesirable effects in relation to mother and fetus when the drug is used by pregnant women.

The use during pregnancy and breastfeeding is possible only in cases when the expected benefit of therapy for the mother exceeds the potential risk for the fetus, therefore, before using the drug it is necessary to consult a physician.

Drugs for topical application, especially after prolonged use, have sensitizing effect. If this occurs, treatment with the drug should be discontinued and, if necessary, appropriate treatment should be prescribed.

With prolonged use of the drug on large areas of the skin and concomitant use of indirect anticoagulants (warfarin, acenocoumarol and others), prothrombin time and blood clotting time should be monitored.

It is not recommended to use the drug Detragel® in deep vein thrombosis.

If the patient's condition worsened or improvement did not occur after 15 days, the patient should consult a doctor.

Storage conditions

The drug should be stored out of reach of children at a temperature not exceeding 25°C.